SOURCE: Fresh Start Private Management Inc.

Fresh Start Private Management Inc.

January 14, 2011 16:00 ET

Fresh Start Private to Build Multiple Revenue Sources Through Partnership Model and Corporately Owned Clinics

Clinics With a Minimum of Three Treatment Rooms Able to Generate up to $120 Million per Year Each

LOS ANGELES, CA--(Marketwire - January 14, 2011) - Fresh Start Private (OTCBB: CEYY), a leader in the alcohol treatment and rehabilitation industry, announced that it will be optimizing shareholder value by creating multiple sources of revenue through both partnerships and corporately owned clinics.

Fresh Start Private's (FSP) goal is to meet its growth targets through partnership opportunities by promoting its product and services to existing medical clinics and treatment centers that will be charged a Licensing fee and a percentage of sales. 

Licensing the FSP idea will:

1. Establish new markets through existing medical centers.
2. Free up capital for company-owned centers and growth
3. Provide ongoing revenue from licensees
4. Build brand awareness faster with consumers

At the same time, FSP has already opened one corporately owned clinic. This first facility is operational and able to treat up to 15 patients a day with potential revenue of $120 Million per year per clinic. The intent is for FSP to open more clinics in areas that show demand and excellent ROI.

There is a vast opportunity for FSP as it rises to meet the need for the treatment of alcoholism in America, and will continue to add to its partnerships and to build on its corporate successes. With a solid management team that is working to anticipate changes with the flexibility and adaptability, FSP will be able to carve out success in this massive marketplace quickly and effectively.

About Fresh Start Private

Fresh Start Private is an alcohol addiction, alcohol withdrawal, alcohol abuse treatment and alcohol detox rehabilitation company on the leading edge of the alcohol addiction treatment. The Company has licensed a highly effective treatment delivers target therapeutic levels of Naltrexone that significantly reduce patients' cravings for alcohol. Please visit  

Statements in this press release may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "optimizing," "potential," "anticipate," "goal," "intend" "intend" and similar expressions, as they relate to the company or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in Fresh Start filings with the Securities and Exchange Commission.

Contact Information